Products for Research Use Only
RegisterLogin

REGN5093-M114

CAT: 0804-HY-171191Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-171191Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
REGN5093-M114 is a bispecific antibody-drug conjugate (ADC) that targets two epitopes of the MET receptor tyrosine kinase inhibits the proliferation of NSCLC cells, exhibits antitumor efficacy in mouse models. REGN5093-M114 is composed of the human monoclonal anti-MET antibody Davutamig and the tubulin-inhibiting linker-payload (HY-148528).
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; c-Met/HGFR; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[REGN5093-M114]
References & Citations
[1]Dardare J, et al., REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer? Transl Lung Cancer Res. 2024 Aug 31;13 (8) :2082-2086.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
Phase 2

Related Products

CatalogName
HY-P1135-01M1145
HY-P1135AM1145 (TFA)
HY-169209CA-M11

Alternative Products

CatalogName
T9901A-768-01REGN5093-M114
GTR18679064-01REGN5093-M114 Antibody
M114-5INTROL TB Panel M114
AS16 3227-1mlAnti-Xylan-3 (clone CCRC-M114)
PTX25721Anti-Human MET/c-Met/HGFR (REGN5093)
TA389045Phospho-AKT1 Mouse Antibody [Clone ID: M114]
WA2121Research Grade Anti-Human MET/c-Met/HGFR (REGN5093)
A135979Anti-MET/c-Met/HGFR (REGN5093) Biosimilar (Monoclonal, IgG)

Popular Products